Thienopyrimidines

US6420368B1 · kind B1 · utility

Assignee

• MERCK PATENT GESELLSCHAFT MIT BESHRANK TER HAFTUNG · DE

Inventors

• Rochus Jonas · Darmstadt, DE
• Pierre Schelling · Mühltal, DE
• Franz-Werner Kluxen · Darmstadt, DE
• Maria Christadler · Darmstadt, DE

Key dates

• Filing date: May 26, 2000
• Grant date: Jul 16, 2002
• Expiry date: May 26, 2020

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The thienopyrimidines of the formula (I) and their physiologically compatible salts display a phosphodiesterase V inhibiting activity and can be used for treating diseases of the cardiovascular system and for treatment and/or therapy of erectile dysfunction.